106 Commerce Street, Suite 105
Lake Mary, FL 32746
TEL: 407.878.7606 • FAX: 407.878.7611
Order additional copies at GuidelineCentral.com
Copyright © 2022 All rights reserved
Disclaimer
is pocket guide is derived om recommendations in the American Society of Clinical Oncolog y
Guideline. is resource is a practice tool based on ASCO
®
practice guidelines and is not intended
to substitute for the independent professional judgment of the treating physician. Practice
guidelines do not account for individual variation among patients. is pocket guide does not
purport to suggest any particular course of medical treatment. Use of the practice guidelines and
this resource are voluntary. e practice guidelines and additional information are available at
www.asco.org/genitourinary-cancer-guidelines. Copyright © 2022 by American Society of Clinical
Oncolog y. All rights reserved.
ASCOOPT2012a_br
Source
Trabulsi EJ et al. Optimum Imaging Strategies for Advanced Prostate Cancer: ASCO
Guideline. J Clin Oncol. 2020 Jun 10;38(17):1963-1996. doi:10.1200/JCO.19.02757. Epub
2020 Jan 15. PMID: 31940221.
ASCO believes that cancer clinical trials are vital to inform medical decisions and
improve cancer care and that all patients should have the opportunity to participate.
Additional information, which may include data supplements, slide sets, and other clinical
tools and resources, is available at www.asco.org/genitourinary-cancer-guidelines.
Recommendation Grading
Type Benefit/harm Evidence Quality
Strength of
Recommendation
EB Evidence-
based
B Benefits
outweigh harms
H High Strong
CB Consensus-
based
H Harms outweigh
benefits
I Intermediate Moderate
IC Informal
consensus
B/H Relative balance
of benefits and
harms
L Low Weak
U Unknown Ins Insufficient
Order No. A91MI-10534-C1-7600 | Printed in the USA | MI-5233 | BEDPRC21-0046 5/22
The printing and distribution of this education resource is sponsored
and provided by Blue Earth Diagnostics, Inc. It is intended for reference
use only and healthcare providers must make clinical judgments based on
their independent assessment of each patient. Blue Earth Diagnostics, Inc.
was not involved in the development of the publication or the underlying
guidelines on which this publication is based.